Abstract:The outbreaks of type O foot-and-mouth disease(FMD) severely affect development of Chinese hog industry,its causative agent is type O foot-and-mouth disease virus(FMDV),which has been evolved several lineages.The available FMD vaccines in China cannot afford sufficient protection against viruses of multi-lineages,which exert important obstacle to disease control.In order to develop vaccine candidate with characteristics of good immunogenicity and broad spectrotype,we constructed a full-length cDNA clone with genetically modified in capsid protein VP3(58 amino acid) and VP1(43,48,137,139,140,141,142 amino acid) based on the infectious cDNA clone of O/HN/93 vaccine strain.Upon cotransfection of BHK-21 cells with linearized recombinant plasmids and plasmids expressing T7 RNA polymerase,the virus was rescued.The results of RT-PCR and sulk mice pathogenicity showed that the rescued virus could be stably maintained during serial passages and has similar pathogenicity with parental virus for sulk mice.To test if the genetically modified virus can be used as a vaccine candidate,the pigs inoculated with inactivated FMD vaccine which made from rV-OSyNa and O/HN/93 viruses were challenged with swine-isolated strains of Chathay,PanAsia and Mya98 topotypes,respectively.As a result,the rV-OSyNa vaccinated pigs were fully protected against three viruses challenge after 28 days post-vaccination,in contrast,16/16 O/HN/93 vaccinated animals fully protected against viruses of PanAsia and Mya98 topotypes challenge,but only 12 /16 O/HN/93 vaccinated animals got protection from virus of Chathay challenge.Our results demonstrated that genetically engineered FMDV is a good vaccine candidate with improving protection against virus of Chathay topotype challenge and expanding spectrotype.

Promising MS2 Mediated Virus-Like Particle Vaccine Against Foot-and-mouth Disease.

Study on MS2 Mediated Virus-like Particles Vaccine Against Foot-and-month Disease

Protection of a Novel Epitope-Rna VLP Double-Effective VLP Vaccine for Foot-and-mouth Disease.

A Novel Mucosal Vaccine Against Foot-and-Mouth Disease Virus Induces Protection in Mice and Swine

Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant.

Poly(I:C) Combined with Multi-Epitope Protein Vaccine Completely Protects Against Virulent Foot-and-mouth Disease Virus Challenge in Pigs

Immunogenicity Evaluation of MS2 Phage-Mediated Chimeric Nanoparticle Displaying an Immunodominant B Cell Epitope of Foot-and-mouth Disease Virus.

Protective Immune Responses Against Foot-And-Mouth Disease Virus by Vaccination with A Dna Vaccine Expressing Virus-Like Particles

Virus-like particles of recombinant PCV2b carrying FMDV-VP1 epitopes induce both anti-PCV and anti-FMDV antibody responses

The High Immunity Induced by the Virus-Like Particles of Foot-and-Mouth Disease Virus Serotype O

Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease

Enhanced Protective Immune Response of Foot-and-mouth Disease Vaccine Through DNA-loaded Virus-Like Particles

Enhanced immunogenicity of multiple-epitopes of foot-and-mouth disease virus fused with porcine interferon α in mice and protective efficacy in guinea pigs and swine

Expression and immunogenicity of capsid protein of porcine circovirus type 2 with N-terminal chimeric neutralizing epitopes of foot-and-mouth disease virus

Synthesis of Empty Capsid-Like Particles of Asia I Foot-And-Mouth Disease Virus in Insect Cells and Their Immunogenicity in Guinea Pigs

Protection of Guinea Pigs and Swine by a Recombinant Adenovirus Expressing O Serotype of Foot-and-mouth Disease Virus Whole Capsid and 3C Protease.

Construction of Genetically Engineered Vaccine Candidate of Type O Foot-and-Mouth-Disease Virus of Pig and Analysis of Its Immunogenicity

Large-scale production of foot-and-mouth disease virus (serotype Asia1) VLP vaccine in Escherichia coli and protection potency evaluation in cattle

Rational Design and Efficacy of a Multi-Epitope Recombinant Protein Vaccine Against Foot-and-mouth Disease Virus Serotype A in Pigs

Enhancement of Serological Immune Responses to Foot-And-Mouth Disease Vaccine by A Supplement Made of Extract of Cochinchina Momordica Seeds

Immune potential of a novel multiple-epitope vaccine to FMDV type Asia 1 in guinea pigs and sheep